Exagen Inc. XGN Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves.
The official record: Exagen Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s deferred tax assets, tax deferred expense, reserves and accruals, loss reserves.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s deferred tax assets, tax deferred expense, reserves and accruals, loss reserves?
- Exagen Inc. (XGN) reported deferred tax assets, tax deferred expense, reserves and accruals, loss reserves of $917K in Q4 2025.
- How has Exagen Inc.'s deferred tax assets, tax deferred expense, reserves and accruals, loss reserves changed year-over-year?
- Exagen Inc.'s deferred tax assets, tax deferred expense, reserves and accruals, loss reserves decreased by 4.0% year-over-year, from $955K to $917K.
- What is the long-term trend for Exagen Inc.'s deferred tax assets, tax deferred expense, reserves and accruals, loss reserves?
- Over 5 years (2020 to 2025), Exagen Inc.'s deferred tax assets, tax deferred expense, reserves and accruals, loss reserves has grown at a -0.1% compound annual growth rate (CAGR), from $920K to $917K.